Stay updated on Extension Study for KarXT Safety in Schizophrenia Clinical Trial
Sign up to get notified when there's something new on the Extension Study for KarXT Safety in Schizophrenia Clinical Trial page.

Latest updates to the Extension Study for KarXT Safety in Schizophrenia Clinical Trial page
- Check3 days agoChange DetectedAdded a comprehensive Locations section listing sites by country and region (e.g., Arizona, California, Sofia-Grad, Tokyo, Cornwall, etc.). The update consolidates multiple location headings into a single Locations section to streamline access for potential participants.SummaryDifference2%

- Check10 days agoChange DetectedThe page now lists additional trial sites across multiple locations and updates the recruitment status for various sites. It also removes several previously listed sites and contacts.SummaryDifference4%

- Check18 days agoChange DetectedThe page no longer lists 'Schizophrenia' as a topic. It also removes the related topic 'MedlinePlus Genetics' from the topics section.SummaryDifference0.0%

- Check25 days agoChange DetectedRevision: v3.3.2 was added, replacing the previous v3.3.1. No study details or page content appear to be affected.SummaryDifference0.0%

- Check32 days agoChange DetectedAdded Local Institution - 316 and Revision v3.3.1 (2025-11-19); removed Rozaliya Rangelova, Site 316, and Lifemed recruitment contact (2025-11-04).SummaryDifference0.2%

- Check39 days agoChange DetectedAdded related topics 'Schizophrenia' and MedlinePlus Genetics; removed the government funding/status notice.SummaryDifference0.1%

Stay in the know with updates to Extension Study for KarXT Safety in Schizophrenia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Extension Study for KarXT Safety in Schizophrenia Clinical Trial page.